SEC Form 4 · accession 0001739452-26-000007
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaobin Wu
Officer — President and COO
Period of report
Jun 16, 2026
Accepted (ET)
Jun 18, 2026 · 5:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | Jun 16, 2026 | S | 1,357 | $266.7626 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 1,290,520 | D | ||
| American Depositary SharesF1 | holding | — | — | — | 12,365 | D | ||
| American Depositary SharesF1 | holding | — | — | — | 4,000 | I | By Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.4658 to $266.8575, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.